Cargando…

C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent

The SBM mouse is a unique transgenic model of polycystic kidney disease (PKD) induced by the dysregulated expression of c-myc in renal tissue. In situ hybridization analysis demonstrated intense signal for the c-myc transgene overlying tubular cystic epithelium in SBM mice. Renal proliferation index...

Descripción completa

Detalles Bibliográficos
Autores principales: Trudel, Marie, Lanoix, Jacqueline, Barisoni, Laura, Blouin, Marie-José, Desforges, Marc, L'Italien, Catherine, D'Agati, Vivette
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199149/
https://www.ncbi.nlm.nih.gov/pubmed/9382886
_version_ 1782148145865555968
author Trudel, Marie
Lanoix, Jacqueline
Barisoni, Laura
Blouin, Marie-José
Desforges, Marc
L'Italien, Catherine
D'Agati, Vivette
author_facet Trudel, Marie
Lanoix, Jacqueline
Barisoni, Laura
Blouin, Marie-José
Desforges, Marc
L'Italien, Catherine
D'Agati, Vivette
author_sort Trudel, Marie
collection PubMed
description The SBM mouse is a unique transgenic model of polycystic kidney disease (PKD) induced by the dysregulated expression of c-myc in renal tissue. In situ hybridization analysis demonstrated intense signal for the c-myc transgene overlying tubular cystic epithelium in SBM mice. Renal proliferation index in SBM kidneys was 10-fold increased over nontransgenic controls correlating with the presence of epithelial hyperplasia. The specificity of c-myc for the proliferative potential of epithelial cells was demonstrated by substitution of c-myc with the proto-oncogene c-fos or the transforming growth factor (TGF)-α within the same construct. No renal abnormalities were detected in 13 transgenic lines established, indicating that the PKD phenotype is dependent on functions specific to c-myc. We also investigated another well characterized function of c-myc, the regulation of apoptosis through pathways involving p53 and members of the bcl-2 family, which induce and inhibit apoptosis, respectively. The SBM kidney tissues, which overexpress c-myc, displayed a markedly elevated (10–100-fold) apoptotic index. However, no significant difference in bcl-2, bax, or p53 expression was observed in SBM kidney compared with controls. Direct proof that the heightened renal cellular apoptosis in PKD is not occurring through p53 was obtained by successive matings between SBM and p53(−/−) mice. All SBM offspring, irrespective of their p53 genotype, developed PKD with increased renal epithelial apoptotic index. In addition, overexpression of both bcl-2 and c-myc in double transgenic mice (SBB(+)/SBM(+)) also produced a similar PKD phenotype with a high apoptotic rate, showing that c-myc can bypass bcl-2 in vivo. Thus, the in vivo c-myc apoptotic pathway in SBM mice occurs through a p53- and bcl-2–independent mechanism. We conclude that the pathogenesis of PKD is c-myc specific and involves a critical imbalance between the opposing processes of cell proliferation and apoptosis.
format Text
id pubmed-2199149
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21991492008-04-16 C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent Trudel, Marie Lanoix, Jacqueline Barisoni, Laura Blouin, Marie-José Desforges, Marc L'Italien, Catherine D'Agati, Vivette J Exp Med Article The SBM mouse is a unique transgenic model of polycystic kidney disease (PKD) induced by the dysregulated expression of c-myc in renal tissue. In situ hybridization analysis demonstrated intense signal for the c-myc transgene overlying tubular cystic epithelium in SBM mice. Renal proliferation index in SBM kidneys was 10-fold increased over nontransgenic controls correlating with the presence of epithelial hyperplasia. The specificity of c-myc for the proliferative potential of epithelial cells was demonstrated by substitution of c-myc with the proto-oncogene c-fos or the transforming growth factor (TGF)-α within the same construct. No renal abnormalities were detected in 13 transgenic lines established, indicating that the PKD phenotype is dependent on functions specific to c-myc. We also investigated another well characterized function of c-myc, the regulation of apoptosis through pathways involving p53 and members of the bcl-2 family, which induce and inhibit apoptosis, respectively. The SBM kidney tissues, which overexpress c-myc, displayed a markedly elevated (10–100-fold) apoptotic index. However, no significant difference in bcl-2, bax, or p53 expression was observed in SBM kidney compared with controls. Direct proof that the heightened renal cellular apoptosis in PKD is not occurring through p53 was obtained by successive matings between SBM and p53(−/−) mice. All SBM offspring, irrespective of their p53 genotype, developed PKD with increased renal epithelial apoptotic index. In addition, overexpression of both bcl-2 and c-myc in double transgenic mice (SBB(+)/SBM(+)) also produced a similar PKD phenotype with a high apoptotic rate, showing that c-myc can bypass bcl-2 in vivo. Thus, the in vivo c-myc apoptotic pathway in SBM mice occurs through a p53- and bcl-2–independent mechanism. We conclude that the pathogenesis of PKD is c-myc specific and involves a critical imbalance between the opposing processes of cell proliferation and apoptosis. The Rockefeller University Press 1997-12-01 /pmc/articles/PMC2199149/ /pubmed/9382886 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Trudel, Marie
Lanoix, Jacqueline
Barisoni, Laura
Blouin, Marie-José
Desforges, Marc
L'Italien, Catherine
D'Agati, Vivette
C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent
title C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent
title_full C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent
title_fullStr C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent
title_full_unstemmed C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent
title_short C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent
title_sort c-myc–induced apoptosis in polycystic kidney disease is bcl-2 and p53 independent
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199149/
https://www.ncbi.nlm.nih.gov/pubmed/9382886
work_keys_str_mv AT trudelmarie cmycinducedapoptosisinpolycystickidneydiseaseisbcl2andp53independent
AT lanoixjacqueline cmycinducedapoptosisinpolycystickidneydiseaseisbcl2andp53independent
AT barisonilaura cmycinducedapoptosisinpolycystickidneydiseaseisbcl2andp53independent
AT blouinmariejose cmycinducedapoptosisinpolycystickidneydiseaseisbcl2andp53independent
AT desforgesmarc cmycinducedapoptosisinpolycystickidneydiseaseisbcl2andp53independent
AT litaliencatherine cmycinducedapoptosisinpolycystickidneydiseaseisbcl2andp53independent
AT dagativivette cmycinducedapoptosisinpolycystickidneydiseaseisbcl2andp53independent